Overcoming Challenges Facing Advanced Therapies in the EU Market.
review · Level V
Where this comes from
- Record sourced from PubMed, PMID 27588746.
- Also identified by DOI 10.1016/j.stem.2016.08.012.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
While advanced therapy medicinal products offer great clinical promise, most EU-approved products have not achieved satisfactory commercial performance. Here we highlight a number of issues that prevent current products from obtaining commercial success and pitfalls that developers must overcome in future product development.
Medical subject headings
- European Union
- Genetic Therapy
- Marketing
- Tissue Engineering